Equipoise, standard of care and consent: responding to the authorisation of new COVID-19 treatments in randomised controlled trials

Abstract

In response to the COVID-19 pandemic, large-scale research and pharmaceutical regulatory processes have proceeded at a dramatically increased pace with new and effective, evidence-based COVID-19 interventions rapidly making their way...